Category: Medical
-
STAT+: How Moderna, the company that helped save the world, unraveled
•
When Moderna CEO Stéphane Bancel addressed the J.P. Morgan Healthcare Conference in January 2021 — virtually, along with…
-
Opinion: STAT+: FDA criticism of MDMA-assisted therapy is an opportunity for psychedelic medicine
•
In September, the Food and Drug Administration released its recent complete response letter (CRL) to Lykos Therapeutics, denying…
-
STAT+: Biden’s law sets Trump up for success in negotiating cheaper Medicare drug prices
•
WASHINGTON — The Trump administration is expected to announce the results of the second round of Medicare drug-price…
-
STAT+: FDA moves to ease path for biosimilars as Trump seeks to cut drug costs
•
WASHINGTON — The Trump administration announced a draft framework Wednesday that officials say will speed cheaper versions of…
-
STAT+: Natera, known for spotting cancer recurrence, wades into early detection
•
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter…
-
STAT+: Pharmalittle: We’re reading about Bausch exiting Medicaid, Lilly and NVIDIA’s supercomputer, and more
•
Rise and shine, everyone, another busy day is on the way. And given that this is the middle…
-
Opinion: U.S. biomedical innovation must not go the way of semiconductors and shipbuilding
•
As President Trump prepares to meet Chinese leader Xi Jinping in a high-stakes attempt to ease renewed trade…
-
What do Rollerblades and Ozempic have in common?
•
If you ask a random person on the street what they call weight loss drugs, odds are, they…
-
STAT+: Casey Means faces confirmation hearing for surgeon general
•
You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and policy of health…
-
STAT+: Bausch Health leaves Medicaid and 340B programs as drugmakers face changing calculus on pricing
•
In an unexpected move, Bausch Health recently stopped participating in Medicaid and a federal government drug discount scheme…
-
STAT+: Pharmalittle: We’re reading about rising GLP-1 use, a psychedelic therapy for depression, and more
•
Rise and shine, everyone, another busy day is on the way. And it is getting off to a…
-
STAT+: Cigna to end drug rebates for many commercial plans
•
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter…
-
STAT+: Syndax leukemia drug wins FDA expanded approval
•
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter…
-
STAT+: Pharmalittle: We’re reading about Organon’s CEO resigning, Cigna ending some rebates, and more
•
Good morning, everyone, and welcome to another working week. We hope the weekend respite was relaxing and invigorating,…
-
STAT+: Generic drugmakers seek to thwart a Connecticut law that would cap rising prices
•
A trade group representing generic drugmakers is seeking an injunction to thwart a provision of a new Connecticut…
-
STAT+: Up and down the ladder: The latest comings and goings
•
Hired someone new and exciting? Promoted a rising star? Finally solved that hard-to-fill spot? Share the news with…
Recent Posts
- How March Madness foes can end UConn’s run through bracket
- Tournament bets: 12-over-5 upset pick and the 2-seed with clearest path to Elite Eight
- March Madness: Odds, spreads and totals for every men’s opening round games
- One Battle After Another’s big night: Key takeaways from the 2026 Oscars
- Liberia: LDEA Seizes Drugs Worth L$7.77 Million At Ganta Border – Guinean National Arrested
- Nigeria: Why I Didn’t Panic After Losing Power – Sanusi
- Liberia: Police Declare Jackson’s Home ‘Restricted’ As Crime Scene Reconstruction Continues in Wife’s Death Probe
- Liberia: NCD Launches Historic Nationwide Tour to Assess Needs of Persons With Disabilities
- Liberia: CDC Raises Concern Over Foya Border Tension and Accuses Government of Risking National Peace
- Nigeria: 2027 – Tinubu Directs His Campaign Group to Donate Rice to Nigerians for Ramadan, Lent
- Nigeria: Mining Dispute – Govt Accuses Jupiter Ltd of Smear Campaign Plot During Tinubu’s UK Visit
- Nigeria: Nigerian Govt Denies ‘British Lithium Project’ Seizure, Alleges Smear Campaign Ahead of Tinubu’s UK Visit
Social Media
Advertisement
